Quick Takeaways
- PROCF - Sofgen Pharma S.A. has 13 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of Sofgen Pharma S.A.
- Symbol
- PROCF, PRCWF on OTC
- Location
- Luxembourg
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Sofgen Pharma S.A. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jose Minski | Director, 10%+ Owner | Mixed | 29 Sep 2021 | |||
| Ruben Minski | Chief Executive Officer, Director, 10%+ Owner | Mixed | 29 Sep 2021 | |||
| Deseja Trust | 10%+ Owner | Mixed | 29 Sep 2021 | |||
| Angelini Melissa Andreia Silva | Interim CEO | Mixed | 18 Mar 2026 | |||
| Camacho Carlos Romero | Director | Mixed | 18 Mar 2026 | |||
| Claro Manuel Jose Vial | Director | Mixed | 18 Mar 2026 | |||
| Muniz Fernando Sebastian Moreira | Director, 10%+ Owner | Mixed | 18 Mar 2026 | |||
| Jaramillo Daniel Augusto Bernal | Director | Mixed | 18 Mar 2026 | |||
| Iragorri Carlos Garcia | Director | Mixed | 18 Mar 2026 | |||
| Alberto Eguiguren | Director | Mixed | 18 Mar 2026 | |||
| Luis Alberto Palacios | Chief Commercial Officer | Mixed | 18 Mar 2026 | |||
| Alexandre Weinstein Manieu | Director, 10%+ Owner | Mixed | 18 Mar 2026 | |||
| Nicolas Alexandre Weinstein | Director | Mixed | 18 Mar 2026 |
Top shareholders of Sofgen Pharma S.A. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Flying Fish Ventures L.P. |
13D/G
|
— |
84%
|
2,077,549,443
|
$2,867,018,231 | $0 | 09 Apr 2025 | |
| Hoche Partners Pharma Holding S.A. |
13D/G
|
— |
84%
|
2,077,549,443
|
$2,867,018,231 | $0 | 16 Apr 2025 | |
| Saint Thomas Commercial S.A. |
13D/G
|
— |
84%
|
2,077,549,443
|
$2,867,018,231 | $0 | 09 Apr 2025 | |
| Becaril S.A. |
13D/G
|
— |
53%
|
1,304,518,234
|
$1,800,235,163 | $0 | 09 Apr 2025 | |
| Chemo Project, S.A. |
13D/G
|
— |
53%
|
1,304,518,234
|
$1,800,235,163 | $0 | 09 Apr 2025 | |
| Alexandre Weinstein Manieu |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
626,495,816
|
— | — | 18 Mar 2026 | |
| Muniz Fernando Sebastian Moreira |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
305,309,149
|
— | — | 18 Mar 2026 | |
| Ruben Minski |
3/4/5
|
Chief Executive Officer, Director, 10%+ Owner |
—
class O/S missing
|
31,338,454
|
— | — | 29 Sep 2021 | |
| Deseja Trust |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
17,960,146
|
— | — | 29 Sep 2021 | |
| Jose Minski |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,960,146
|
— | — | 29 Sep 2021 |
Recent Insider Transactions by Companies or Individuals for Sofgen Pharma S.A.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Muniz Fernando Sebastian Moreira | PROCF | Ordinary Shares | 0 | 305,309,149 | 18 Mar 2026 | By Becaril S.A. | ||||
| Alexandre Weinstein Manieu | Ordinary Shares | 0 | 626,495,816 | 18 Mar 2026 | By Hoche Partners Pharma Holdings LLC |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.